BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32471111)

  • 1. Increase in the Number of Bone Marrow Osteoclast Precursors at Different Skeletal Sites, Particularly in Long Bone and Jaw Marrow in Mice Lacking IL-1RA.
    Ascone G; Cao Y; Jansen IDC; Di Ceglie I; van den Bosch MHJ; Blom AB; van Lent PLEM; Everts V; de Vries TJ
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
    Cao Y; Jansen ID; Sprangers S; Stap J; Leenen PJ; Everts V; de Vries TJ
    J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaw and long bone marrows have a different osteoclastogenic potential.
    de Souza Faloni AP; Schoenmaker T; Azari A; Katchburian E; Cerri PS; de Vries TJ; Everts V
    Calcif Tissue Int; 2011 Jan; 88(1):63-74. PubMed ID: 20862464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α has both stimulatory and inhibitory effects on mouse monocyte-derived osteoclastogenesis.
    Cao Y; Jansen IDC; Sprangers S; de Vries TJ; Everts V
    J Cell Physiol; 2017 Dec; 232(12):3273-3285. PubMed ID: 28543070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
    Yamazaki H; Kunisada T; Yamane T; Hayashi SI
    Exp Hematol; 2001 Jan; 29(1):68-76. PubMed ID: 11164107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
    Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
    PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone.
    Wan Q; Schoenmaker T; Jansen ID; Bian Z; de Vries TJ; Everts V
    Bone; 2016 May; 86():10-21. PubMed ID: 26921824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.
    Tsurukai T; Takahashi N; Jimi E; Nakamura I; Udagawa N; Nogimori K; Tamura M; Suda T
    J Cell Physiol; 1998 Oct; 177(1):26-35. PubMed ID: 9731742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout mice.
    Di Ceglie I; van Lent PLEM; Geven EJW; Koenders MI; Blom AB; Vogl T; Roth J; van den Bosch MHJ
    Arthritis Res Ther; 2021 Aug; 23(1):216. PubMed ID: 34412663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
    Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
    Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model.
    Tanaka K; Hashizume M; Mihara M; Yoshida H; Suzuki M; Matsumoto Y
    Clin Exp Immunol; 2014 Feb; 175(2):172-80. PubMed ID: 24028747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
    Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood.
    Zhang Q; Guo R; Schwarz EM; Boyce BF; Xing L
    Arthritis Res Ther; 2008; 10(2):R37. PubMed ID: 18371213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
    Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
    J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
    Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
    J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaw bone marrow-derived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors.
    Vermeer JA; Jansen ID; Marthi M; Coxon FP; McKenna CE; Sun S; de Vries TJ; Everts V
    Bone; 2013 Nov; 57(1):242-51. PubMed ID: 23962725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.
    Yang X; Pande S; Scott C; Friesel R
    J Cell Biochem; 2019 Aug; 120(8):12450-12460. PubMed ID: 30805994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression.
    Yao Z; Li P; Zhang Q; Schwarz EM; Keng P; Arbini A; Boyce BF; Xing L
    J Biol Chem; 2006 Apr; 281(17):11846-55. PubMed ID: 16461346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.